Результаты поиска

Многодисциплинарное групповое вмешательство для лиц, живущих с множественной миеломой: технико-экономическое обоснование.

Несмотря на то, что множественные миеломы по-прежнему являются неизлечимым раком, прогресс в их понимании и управлении ими привел к значительному повышению показателей выживаемости. По-прежнему мало случаев оказания помощи лицам, живущим с множественными миеломами, несмотря на рост числа случаев неудовлетворенных потребностей в поддержке среди многих выживших жертв миэломы. Нынешнее исследование направлено на оценку осуществимости и предварительной эффективности новаторского многодисциплинарного группового мероприятия по оказанию помощи лицам, пережившим миэлому. МЕТОДЫ: В рамках обычной служб

Совпадение в полном тексте источника
… Determining the minimal clinically important difference criteria for the Multidimensional Fatigue Inventory in a radiotherapy population. Support Care Cancer. 2010;18:307–315. doi: 10.1007/s00520-009-0653-z. 46. Edbrooke-Childs J, Jacob J, Law D, Deighton J, Wolpert M. …

Эффективность транскраниальной непосредственной стимуляции тока на двигательных и когнитивных функциях у пациентов с множественным склерозом: систематический обзор и метаанализ.

Множественный склероз (MS) представляет собой хроническое неврологическое расстройство, затрагивающее 2.8 million :: люди во всем мире, характеризующиеся дисфункцией двигателя и когнитивными нарушениями, которые по-прежнему плохо решаются только с помощью фармакологических средств. Транскраниальное прямое стимулирование течения (tDCS) стало многообещающей неинвазивной нейромодуляцией для лечения симптомов у пациентов с синдромом MS. ЦЕЛИ: Этот систематический обзор и метаанализ были направлены на оценку эффективности ТДСЦ в деле совершенствования двигательных и когнитивных функций у пациентов

Novel Developments in the Treatment of Multiple Myeloma-Associated Bone Disease.

Osteolytic bone disease is present in about 80% of patients with multiple myeloma at the time of diagnosis. Managing bone disease in patients with multiple myeloma is a challenge and requires a multi-faceted treatment approach with medication, surgery, and radiation. The established treatments with intravenous or subcutaneous antiresorptives can cause debilitating adverse events for patients, mainly osteonecrosis of the jaw, which, traditionally, has been difficult to manage. Now, oral surgery is recommended and proven successful in 60-85% of patients. Patients with spinal involvement may bene

Выборочные связи между когнитивной практикой и реактивной адаптацией в множестве склерозов.

ЦЕЛЬ: Когнитивные и балансовые нарушения характерны для множественных склерозов (МС). Эффекты на практике могут отражать нейропластичность и прогнозировать реабилитацию. В ходе этого исследования были изучены когнитивные последствия и их связь с реактивной адаптацией баланса в НР. МЕТОДЫ: Twenty-seven люди, имеющие MS и 17 Нейротипичные взрослые 2 базовые когнитивные оценки по сравнению с 2 недель, за которыми следует a 2-week Программа профессиональной подготовки по вопросам сбалансированности на основе транстурбации 6 - прогрессивные сессии. Вертикальная скорость обучения и обработки была оц

Совпадение в полном тексте источника
… For example, on the Symbol Digit Modalities Test (SDMT), a key measure of processing speed, practice gains are modest and often approach the minimal clinically important difference (≈3–4 points), with performance plateauing after multiple assessments ( Novakova et al., 2025 ). …

Novel Strategies for Tumor Treatment: Harnessing ROS-Inducing Active Ingredients from Traditional Chinese Medicine Through Multifunctional Nanoformulations.

Reactive oxygen species (ROS) encompass a diverse group of chemically reactive molecules or ions distinguished by their substantial oxidative potential. Empirical studies have shown that the targeted administration of high toxic concentrations of ROS can effectively induce tumor cell death in various types. Numerous bioactive ingredients derived from traditional Chinese medicine (TCM), recognized for their ROS-inducing properties, have demonstrated significant anti-tumor activity. Nonetheless, their clinical application has been hindered by challenges such as low solubility, limited bioavailab

Assessing Cachexia Acutely after Autologous Stem Cell Transplant.

Autologous hematopoietic stem cell transplantation (AHCT) is an accepted strategy for various hematologic malignancies that can lead to functional impairment, fatigue, muscle wasting, and reduced quality of life (QOL). In cancer cachexia, these symptoms are associated with inflammation, hypermetabolism, and decreased anabolic hormones. The relative significance of these factors soon after AHCT setting is unclear. The purpose of this study was to characterize the acute effects of AHCT on physical function, body composition, QOL, energy expenditure, cytokines, and testosterone. Outcomes were ass

Совпадение в полном тексте источника
… A systematic review comprised of studies including patients with chronic obstructive pulmonary disease, lung cancer, coronary artery disease, other lung diseases, or adults with fear of falling, reported that the minimal clinically important difference, determined with ≥70% specificity via receiver operating … Minimal clinically important difference for change in 6-minute walk test distance of adults with pathology: A systematic review. J. Eval. Clin. Pract. 2017;23:377–381. doi: 10.1111/jep.12629. 9. Jatoi A., Daly B.D., Hughes V.A., Dallal G.E., Kehayias J., Roubenoff R. …

Достижения в области циркуляции биомаркеров нейродегенеративных заболеваний, травматологических травм мозга и опухолей центральной нервной системы.

Неврологические расстройства, включая нейродегенеративные заболевания, травматические травмы мозга (ТБИ) и опухоли центральной нервной системы (ЦНС), являются сложными условиями, которые оказывают значительное воздействие на пациентов во всем мире. Своевременная диагностика и мониторинг имеют решающее значение для улучшения результатов, что обусловливает потребность в надежных биомаркерах. В частности, биомаркеры, обнаруживаемые в цереброспиновой жидкости (CSF) и крови, позволяют получить важные данные о наличии и прогрессировании заболеваний. В рамках этого обзора изучается эволюция циркулиру

The Role of Monoclonal Antibodies in Smoldering and Newly Diagnosed Transplant-Eligible Multiple Myeloma.

The recent introduction of monoclonal antibodies (MoAbs), with several cellular targets, such as CD-38 (daratumumab and isatuximab) and SLAM F7 (elotuzumab), differently combined with other classes of agents, has significantly extended the outcomes of patients with multiple myeloma (MM) in different phases of the disease. Initially used in advanced/refractory patients, different MoAbs combination have been introduced in the treatment of newly diagnosed transplant eligible patients (NDTEMM), showing a significant improvement in the depth of the response and in survival outcomes, without a signi

Использование данных о реальных требованиях для оценки распространенности конкомитативных лекарств для информирования о риске взаимодействия между наркотиками и наркотиками среди целевых групп пациентов.

Одной из общих проблем в области развития клинических наркотиков является взаимодействие между наркотиками и наркотиками (ДДИ), которое может привести к изменению воздействия наркотиков и последующему изменению безопасности и эффективности следственного препарата или сопутствующих ему лекарственных препаратов (кондекций) среди целевой группы пациентов. Таким образом, трубопровод для разработки лекарств включает оценку рисков, связанных с диагностикой наркотиков, на основе исследований in vitro, моделирования силико и клинических испытаний. Данные о реальном мире (ДСР), в частности базы данных

Chimeric antigen receptor therapy for hematological malignancies: a pediatric perspective from leukapheresis to infusion.

Immunotherapy, particularly chimeric antigen receptor T cells (CAR T)s, has changed the landscape of B-cell malignancy treatment and represents a promising approach to cancer therapy. The use of CAR T-based therapy in pediatric patients presents several critical issues such as the quality of the leukapheresis process and the treatment-related toxicity. Nevertheless, the experience with anti-CD19 CAR Ts in treating pediatric B-cell precursor acute lymphoblastic leukemia (BCP-ALL) demonstrated its feasibility and efficacy with a complete response rate greater than 80%. Although CAR T therapy is

A prospective, multicenter, observational study of ixazomib plus lenalidomide-dexamethasone in patients with relapsed/refractory multiple myeloma in Japan.

Real-world studies permit inclusion of a more diverse patient population and provide more information on the effectiveness of treatments used in routine clinical practice. This prospective, multicenter, observational study investigated the effectiveness and safety of ixazomib plus lenalidomide and dexamethasone (IRd) in 295 patients with relapsed/refractory multiple myeloma (RRMM) in routine clinical practice in Japan. Patients had a median age of 74 years, 80.0% were aged ≥ 65 years, 42.0% had received ≥ 3 lines of prior treatment, and 28.5% were "frail" according to the International Myeloma

An 8-step approach for the systematic development of an evidence-based exercise program for patients undergoing hematopoietic stem cell transplantation.

BackgroundA tailored and reliable intervention program developed based on evidence is necessary for patients with serious health conditions.ObjectiveWe describe the development of an exercise program for HSCT patients based on evidence from a systematic process.MethodsWe developed the exercise program for HSCT patients using eight systematic steps: (1) a literature review, (2) understanding patient characteristics, (3) first expert group discussion, (4) development of the first draft of the exercise program, (5) a pre-test, (6) second expert group discussion, (7) a pilot randomized controlled

Разработка интерактивной прикладной программы биоразведки для оценки декстерности пальцев.

ЦЕЛЬ: Точная оценка функции пальца имеет решающее значение для контроля за ежедневной деятельностью рук. Однако для оценки различных задач, связанных с использованием пальцев, не хватает специализированных цифровых приложений. Цель этого исследования заключается в разработке индивидуального прикладного программного обеспечения цифрового биоразведки для оценки декситеритности пальцев. МЕТОДЫ: Мы разработали цифровую программу биоразведки, совместимую с смартфонами и таблетками, которая позволяет 3-min испытание на декстерминацию пальцев, измерение скорости и точности для каждого пальца и каждог

Reduced-versus Standard-dose Melphalan as Single-agent Conditioning Regimen in Auto HSCT for Multiple Myeloma: A Systematic Review and Meta-Analysis.

BackgroundThe optimal conditioning dose of melphalan for autologous hematopoietic stem cell transplantation (AHSCT) in multiple myeloma remains a subject of debate. While prior studies have presented conflicting evidence on whether standard-dose melphalan (SDM, 200 mg/m2) provides a statistically significant survival advantage over reduced-dose melphalan (RDM, 140 mg/m2), further investigation is necessary to clarify this.AimThis systematic review and meta-analysis aimed to consolidate existing studies and assess whether standard-dose melphalan confers a significant benefit in terms of overall

Therapeutic Antibodies in Hematology: Advances in Malignant and Non-Malignant Disorders.

Therapeutic antibodies have revolutionized hematology, offering targeted and effective treatments for both malignant and non-malignant diseases. In hematologic malignancies, anti-CD20, anti-CD19, anti-CD38, and anti-B-cell maturation antigen (BCMA) antibodies have markedly improved survival outcomes, whereas antibody-drug conjugates and bispecific antibodies continue to expand therapeutic possibilities. Besides cancer, complement inhibitors such as eculizumab, ravulizumab, and the recently approved crovalimab have redefined paroxysmal nocturnal hemoglobinuria and atypical hemolytic uremic synd

Immunoglobulin A Nephropathy: Molecular Pathogenesis and Targeted Therapy.

Immunoglobulin A nephropathy (IgAN), the most prevalent primary glomerulonephritis globally, is characterized by mesangial IgA deposition and heterogeneous clinical trajectories. Historically, management relied on renin-angiotensin system inhibition and empirical immunosuppression, yet high lifetime kidney failure risk persists despite optimized care. This review synthesizes advances in molecular pathogenesis, highlighting how the traditional multi-hit hypothesis-while foundational for targeted therapy development-fails to capture IgAN's recurrent, self-amplifying nature. We introduce the "spi

The direct and indirect effects of COVID-19 pandemic in a real-life hematological setting.

BackgroundClinical outcomes of novel coronavirus 2019 disease (COVID-19) in onco-hematological patients are unknown. When compared to non-immunocompromised patients, onco-hematological patients seem to have higher mortality rates.AimsWe describe the characteristics and outcomes of a consecutive cohort of 24 onco-hematological patients with COVID-19 during the first month of the pandemic. We also describe variations in healthcare resource utilization within our hematology department.Methods and resultsData from patients between the first month of the pandemic were retrospectively collected. Cli

Anti-cancer mechanisms of action of therapeutic alternating electric fields (tumor treating fields [TTFields]).

Despite improved survival outcomes across many cancer types, the prognosis remains grim for certain solid organ cancers including glioblastoma and pancreatic cancer. Invariably in these cancers, the control achieved by time-limited interventions such as traditional surgical resection, radiation therapy, and chemotherapy is short-lived. A new form of anti-cancer therapy called therapeutic alternating electric fields (AEFs) or tumor treating fields (TTFields) has been shown, either by itself or in combination with chemotherapy, to have anti-cancer effects that translate to improved survival outc

Progress in the application of 68Ga-Pentixafor PET/CT in lung cancer: a review.

68Ga-Pentixafor PET/CT, a molecular imaging technique targeting the C-X-C chemokine receptor 4 (CXCR4), has emerged as a promising tool in the diagnosis and therapeutic evaluation of lung cancer. Lung cancer remains a leading cause of cancer-related mortality worldwide, and accurate imaging modalities are critical for early detection, staging, and treatment monitoring. Current imaging approaches face challenges in differentiating tumor subtypes and assessing tumor biology, which limits personalized treatment strategies. This review systematically summarizes the application of 68Ga-Pentixafor P

Treating Protein Misfolding Diseases: Therapeutic Successes Against Systemic Amyloidoses.

Misfolding and extracellular deposition of proteins is the hallmark of a heterogeneous group of conditions collectively termed protein misfolding and deposition diseases or amyloidoses. These include both localized (e.g. Alzheimer's disease, prion diseases, type 2 diabetes mellitus) and systemic amyloidoses. Historically regarded as a group of maladies with limited, even inexistent, therapeutic options, some forms of systemic amyloidoses have recently witnessed a series of unparalleled therapeutic successes, positively impacting on their natural history and sometimes even on their incidence. I